Diagnamed Holdings Corp.
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It has a collaboration agreement with EIREX for the development and commerc… Read more
Diagnamed Holdings Corp. (DGNMF) - Total Assets
Latest total assets as of September 2025: $216.36K USD
Based on the latest financial reports, Diagnamed Holdings Corp. (DGNMF) holds total assets worth $216.36K USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Diagnamed Holdings Corp. - Total Assets Trend (2021–2025)
This chart illustrates how Diagnamed Holdings Corp.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Diagnamed Holdings Corp. - Asset Composition Analysis
Current Asset Composition (September 2025)
Diagnamed Holdings Corp.'s total assets of $216.36K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 85.0% |
| Accounts Receivable | $17.60K | 8.1% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Diagnamed Holdings Corp.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Diagnamed Holdings Corp.'s current assets represent 100.0% of total assets in 2025, unchanged from 100.0% in 2021.
- Cash Position: Cash and equivalents constituted 85.0% of total assets in 2025, down from 98.7% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 8.1% of total assets.
Diagnamed Holdings Corp. Competitors by Total Assets
Key competitors of Diagnamed Holdings Corp. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
Diagnamed Holdings Corp. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Diagnamed Holdings Corp. generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Diagnamed Holdings Corp. is currently not profitable relative to its asset base.
Diagnamed Holdings Corp. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.32 | 0.43 | 4.37 |
| Quick Ratio | 0.32 | 0.43 | 4.37 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-450.11K | $ -265.17K | $ 1.25 Million |
Diagnamed Holdings Corp. - Advanced Valuation Insights
This section examines the relationship between Diagnamed Holdings Corp.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 14.58 |
| Latest Market Cap to Assets Ratio | 7.54 |
| Asset Growth Rate (YoY) | 7.2% |
| Total Assets | $216.36K |
| Market Capitalization | $1.63 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Diagnamed Holdings Corp.'s assets at a significant premium ( 7.54x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Diagnamed Holdings Corp.'s assets grew by 7.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Diagnamed Holdings Corp. (2021–2025)
The table below shows the annual total assets of Diagnamed Holdings Corp. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $216.36K | +7.24% |
| 2024-09-30 | $201.75K | -69.54% |
| 2023-09-30 | $662.27K | -59.01% |
| 2022-09-30 | $1.62 Million | -32.40% |
| 2021-09-30 | $2.39 Million | -- |